Cargando…
Comprehensive methylome sequencing reveals prognostic epigenetic biomarkers for prostate cancer mortality
BACKGROUND: Prostate cancer is a clinically heterogeneous disease with a subset of patients rapidly progressing to lethal‐metastatic prostate cancer. Current clinicopathological measures are imperfect predictors of disease progression. Epigenetic changes are amongst the earliest molecular changes in...
Autores principales: | Pidsley, Ruth, Lam, Dilys, Qu, Wenjia, Peters, Timothy J., Luu, Phuc‐Loi, Korbie, Darren, Stirzaker, Clare, Daly, Roger J., Stricker, Phillip, Kench, James G., Horvath, Lisa G., Clark, Susan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523674/ https://www.ncbi.nlm.nih.gov/pubmed/36178085 http://dx.doi.org/10.1002/ctm2.1030 |
Ejemplares similares
-
Comprehensive evaluation of targeted multiplex bisulphite PCR sequencing for validation of DNA methylation biomarker panels
por: Lam, Dilys, et al.
Publicado: (2020) -
MethPanel: a parallel pipeline and interactive analysis tool for multiplex bisulphite PCR sequencing to assess DNA methylation biomarker panels for disease detection
por: Luu, Phuc-Loi, et al.
Publicado: (2020) -
Advances in Prognostic Methylation Biomarkers for Prostate Cancer
por: Lam, Dilys, et al.
Publicado: (2020) -
Enduring epigenetic landmarks define the cancer microenvironment
por: Pidsley, Ruth, et al.
Publicado: (2018) -
Identification of DNA methylation biomarkers with potential to predict response to neoadjuvant chemotherapy in triple-negative breast cancer
por: Meyer, Braydon, et al.
Publicado: (2021)